Crizotinib-d8, CAS [[1523579-82-9]] Preis auf Anfrage

Artikelnummer: MCE-HY-50878S1
Artikelname: Crizotinib-d8, CAS [[1523579-82-9]] Preis auf Anfrage
Artikelnummer: MCE-HY-50878S1
Hersteller Artikelnummer: HY-50878S1
Alternativnummer: MCE-HY-50878S1-1UNIT
Hersteller: MedchemExpress
Kategorie: Biochemikalien
Alternative Synonym: PF-02341066-d8
Crizotinib-d8 (PF-02341066-d8) is deuterium labeled Crizotinib. Crizotinib (PF-02341066) is an orally bioavailable, ATP-competitive ALK and c-Met inhibitor with IC50s of 20 and 8 nM, respectively. Crizotinib inhibits tyrosine phosphorylation of NPM-ALK and tyrosine phosphorylation of c-Met with IC50s of 24 and 11 nM in cell-based assays, respectively. Crizotinib is also a ROS1 inhibitor. Crizotinib has effective tumor growth inhibition[1][2][3].
Molekulargewicht: 458.39
CAS Nummer: [1523579-82-9]
Formel: C21H14D8Cl2FN5O
Target-Kategorie: Anaplastic lymphoma kinase (ALK),Autophagy,c-Met/HGFR,Isotope-Labeled Compounds,ROS Kinase
Anwendungsbeschreibung: MCE Product type: Isotope-Labeled Compounds